Translational Medicine in Drug Development - Bioanalytical Lab & Top CRO for Bioanalysis

Bioanalytical Needs And Biosimilars: How Does The Molecule Compare?

January 3, 2023

Once the patent on a previously ground-breaking blockbuster molecule comes to an end, there is an opportunity for biosimilar versions

Trends Paving The Way For An Influx Of Biosimilar Development

January 3, 2023

Promising broader patient access to critical medicines, biosimilars offer a more cost-effective alternative therapeutic option compared with originator products. With

Now Streaming On-Demand

In association with Oxford Global, this webinar will highlight how to properly structure your program and get an in-depth look at the critical parameters needed for a fit-for-purpose approach. You will learn the key assay validation parameters to produce a reliable bioanalytical assay generating data for your decision-making.

About the Presenter:

Marianne Scheel Fjording is a Scientific Officer at BioAgilytix. Marianne has an extensive background in large molecule bioanalytical assay set-up and assay validation. She has 20+ years of experience working in the pharmaceutical and biotechnology industry. Prior to joining BioAgilytix, she was Scientific Director at Novo Nordisk (Copenhagen, Denmark) where she delivered bioanalytical strategies for PK and biomarker assays.